Cargando…
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases
ESSENTIALS: Patients with liver diseases may acquire substantial changes in all components of hemostasis. Hemostasis is in unstable balance due to simultaneous changes in pro‐ and antihemostatic systems. Intrahepatic activation of hemostasis may contribute to disease progression. Optimal strategies...
Autores principales: | Lisman, Ton, Porte, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058283/ https://www.ncbi.nlm.nih.gov/pubmed/30046685 http://dx.doi.org/10.1002/rth2.12028 |
Ejemplares similares
-
Pathophysiology and management of bleeding and thrombosis in patients with liver disease
por: van den Boom, Bente P., et al.
Publicado: (2022) -
Bleeding and Thrombosis in Patients With Cirrhosis: What’s New?
por: Lisman, Ton
Publicado: (2023) -
Treatment of bleeding in patients with liver disease
por: Northup, Patrick G., et al.
Publicado: (2021) -
Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival
por: Alkozai, Edris M, et al.
Publicado: (2014) -
Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice
por: Karimian, Golnar, et al.
Publicado: (2015)